INSM1 Antibodies

Santa Cruz Biotechnology offers a broad range of INSM1 monoclonal antibodies for advanced research in molecular biology. INSM1 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). INSM1, or Insulinoma-Associated Protein 1, plays a critical role in neuroendocrine differentiation and is essential for the development of neuroendocrine tumors. Its expression is often associated with various cancers, making INSM1 a significant marker for diagnostic and therapeutic applications. Understanding INSM1 function can provide insights into tumor biology and potential treatment strategies. Researchers can investigate INSM1 expression patterns in different tissue types to better understand its role in cellular development and disease progression. The molecular characterization of INSM1 can reveal new pathways involved in neuroendocrine differentiation and tumor formation. INSM1 studies may also uncover novel therapeutic targets for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies targeting INSM1 enable researchers worldwide to advance our understanding of neuroendocrine development and cancer biology.